SUNNYVALE, Calif., May 6 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq:
CPHD) announced today that the Company will present at the following
-- The Robert W. Baird Growth Stock Conference on May 13 at 12:15 p.m. EDT
at The Four Seasons Hotel in Chicago
-- The Bank of America Healthcare Conference on May 14 at 3:40 p.m. EDT at
The Four Seasons Hotel in Las Vegas
John Bishop, Chief Executive Officer, and Andrew Miller, Senior Vice President, Chief Financial Officer, will provide a corporate overview at each conference.
Live webcasts, along with accompanying presentation slides, may be accessed on Cepheid's Web site at http://www.cepheid.com under Investors: Events: Webcasts and Presentations. A replay of the webcast presentations will be available for 90 days following the live events.
Cepheid (Nasdaq: CPHD), based in Sunnyvale, California, is a molecular
diagnostics company that develops, manufactures, and markets
fully-integrated systems and tests for genetic analysis in the clinical,
industrial and biothreat markets. The company's systems enable rapid,
sophisticated genetic testing for organisms and genetic-based diseases by
automating otherwise complex manual laboratory procedures. The company's
easy-to-use systems integrate a number of complicated and time-intensive
steps, including sample preparation, DNA amplification and detection, which
enable the analysis of complex biological samples in its proprietary test
cartridges. Through its strong molecular biology capabilities, the company
is focusing on those applications where rapid molecular testing is
particularly important, such as iden
Copyright©2008 PR Newswire.
All rights reserved